NCT05492682 2026-05-12START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerValo Therapeutics OyPhase 1 Recruiting15 enrolled
NCT06644755 2025-07-24First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsDaiichi SankyoPhase 1 Recruiting150 enrolled